Latest on Pharmaceutical Industry


Zogenix's seizure drug clears late-stage trial, shares soar

Zogenix Inc  said on Thursday its drug to treat a rare form of childhood epilepsy reduced convulsive seizures in a second late-stage trial, sending the drug developer’s shares up as much as 26 percent. The successf..Read More...

Otsuka Pharmaceutical to Acquire Visterra

Otsuka Pharmaceutical Co., Ltd. (Otsuka) and Visterra, Inc. (Visterra) announce that they have entered into a definitive merger agreement pursuant to which Otsuka will acquire Visterra for approximately USD 430 million i..Read More...



Tumor Models Boston 2018

Revere Hotel Boston Common,
Hanson Wade


World Congress on Advanced Pharmacy and Clinical Research

Conferenceseries LLC

Press Releases

Landos Biopharma Initiates Phase 1 Clinical Trial of BT-11, an Oral LANCL2 Agonist for Treatment of IBD

Landos Biopharma Inc a clinicalstage biopharmaceutical company focused on developing improved treatments for autoimmune diseases announced today that the first healthy subjects have been dosed in a Phase 1 clinical study.. Read More...

Aurinia Initiates Phase 2 Clinical Trial for Voclosporin Ophthalmic Solution for the Treatment of Dry Eye Syndrome

Aurinia Pharmaceuticals Inc a clinical stage biopharmaceutical company focused on the global immunology market today announced the initiation of its Phase 2 trial evaluating voclosporin ophthalmic solution VOS for the tr.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Zaphyr Pharma

Zaphyr Pharma Dr Manel Chikh is the founder and CEO of Zaphyr Pharmaceuticals a pharma company that commercializes specialty products in the MEA region Founded in 2012 Zaphyr focuses on oncology and rare diseases and operates between Switzerland Ireland and Dubai. Read More...
Manel Chikh